Relationship between esophageal cancer-related gene 2 polymorphism and esophageal squamous cell carcinomas in Kazakhs and Hans of Xinjiang.

Limin Gao, Jun Li, Yi Zheng

Open access · greenAbstract read

In one paragraph

Article in International journal of clinical and experimental pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact, top 84% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

ECRG2/SPINK7 Tumor Suppressor as Modulator of DNA Damage Response.International journal of molecular sciences · 2024
Review

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Limin GaoDepartment of Obstetrics and Gynecology, The First Affiliated Hospital, Shihezi University School of Medicine Shihezi, Xinjiang, China.

Jun LiDepartment of Ultrasound, The First Affiliated Hospital, Shihezi University School of Medicine Shihezi, Xinjiang, China.

Yi ZhengDepartment of Gastroenterology, The First Affiliated Hospital, Shihezi University School of Medicine Shihezi, Xinjiang, China.

Shihezi University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, many studies have focused on the novel esophageal cancer-related gene 2 (ECRG2), which might be important in esophageal cancer development. The aim of this study is to investigate the relationship between ECRG2 short tandem repeat (STR) polymorphism and susceptibility to esophageal squamous cell carcinomas (ESCCs) in Kazakhs and Hans in Xinjiang. ECRG2 genotypes were detected by PCR-SSCP in 178 cases of esophageal carcinomas and 153 blood samples from the Kazakh and Han population. In Kazakhs and Hans, the frequencies of ECRG2 STR genotypes TCA3/TCA3, TCA4/TCA4, and TCA3/TCA4 were 47.8%/8.7%, 43.5%/67.9%, and 7.1%/25.0% in esophageal carcinomas with metastasis, respectively; and 14.1%/38%, 47.9%/14.3%, and 44.6%/41.1% in carcinomas without metastasis, respectively. A significant difference was observed between the groups with metastasis and without metastasis (Kazakh: χ

Indexed as

ECRG2Esophageal cancergenetic polymorphismHanKazakh populationSTR

Identifiers

PMID31934184

PMCPMC6949829

OpenAlexW3027976202

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.